2018, Number 6
PDF size: 270.54 Kb.
ABSTRACTGlobal developmental delay (GDD) and intellectual disability (ID) constitute frequent problems that health care professionals constantly face. Most intellectual disabilities are diagnosed in the school age period or later. It is fundamental to know the diagnostic criteria to both entities, identify key clinical information to guide appropriate patient referrals, and to ensure an efficient clinical approach. Practice guidelines from international consensus have provided detailed information regarding the diagnostic approach to patients with GDD or ID; however, their implementation is difficult due to cost-efficiency and resource limitations. We present a review of current literature on GDD and DI. From an international perspective, we have also addressed those articles that include recommendations and statements of professional organizations. We have considered the geographical context, in particular to Latin American countries.
Bagnato SJ, Macey M, Salaway J, Lehman C. Research foundations for conventional tests and testing to ensure accurate and representative early intervention eligibility. Pittsburgh, PA: Children´s Hospital of Pittsburg of UPMC; Early Childhood Partnerships-TRACE Center for Excellence, and US Department of Education, Office of Special Education Programs; 2007. p. 1-48.
Council on Children With Disabilities; Section on Developmental Behavioral Pediatrics; Bright Futures Steering Committee; Medical Home Initiatives for Children With Special Needs Project Advisory Committee. Identifying infants and young children with developmental disorders in the medical home: an algorithm for developmental surveillance and screening. Pediatrics. 2006;118(1):405-20.
Shevell M, Ashwal S, Donley D, Flint J, Gingold M, Hirtz D, et al. Practice parameter: evaluation of the child with global developmental delay: report of the Quality Standars Subcommittee of the American Academy of Neurology and The Practice Committee of the Child Neurology Society. Neurology. 2003;60(3):367-80.
Battaglia A, Doccini V, Bernardini L, Novelli A, Loddo S, Capalbo A, et al. Confirmation of chromosomal microarray as a first-tier clinical diagnostic test for individuals with developmental delay, intellectual disability, autism spectrum disorders and dysmorphic features. Eur J Paediatr Neurol. 2013;17(6):589-99.
Michelson DJ, Shevel MI, Sherr EH, Moeschler JB, Gropman AL, Ashwal S. Evidence report: Genetic and metabolic testing on children with global developmental delay: report of the Quality Standars Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2011;77(17): 1629-35.